Apogee Therapeutics, Inc. APGE Operating Lease ROU Assets
Operating Lease ROU Assets at other companies
Other financials
Where this comes from
Reported directly by Apogee Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.
The official record: Apogee Therapeutics, Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Apogee Therapeutics, Inc.'s operating lease rou assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Apogee Therapeutics, Inc.'s operating lease ROU assets?
- Apogee Therapeutics, Inc. (APGE) reported operating lease ROU assets of $7.71M in Q1 2026.
- How has Apogee Therapeutics, Inc.'s operating lease ROU assets changed year-over-year?
- Apogee Therapeutics, Inc.'s operating lease ROU assets decreased by 33.0% year-over-year, from $11.51M to $7.71M.
- What is the long-term trend for Apogee Therapeutics, Inc.'s operating lease ROU assets?
- Over 2 years (2023 to 2025), Apogee Therapeutics, Inc.'s operating lease ROU assets has grown at a 97.9% compound annual growth rate (CAGR), from $2.22M to $8.69M.
- What does operating lease ROU assets mean?
- Right-of-use assets representing the lessee's right to use leased property over the lease term under ASC 842 operating lease classification.